Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Carrascosa

Showing results (111-120 of 242) with videos related to

Pageof 25
Sort By:
Clinical and Experimental Dermatology|October 23, 2012
Lipopolysaccharide-binding protein is increased in patients with psoriasis with metabolic syndrome, and correlates with C-reactive proteinJ Romaní, A Caixàs, X Escoté, et al.
Actas Dermo-Sifiliograficas|March 9, 2025
Expert Recommendations on Topical Therapy for Psoriasis from the Spanish Psoriasis Working Group (GPS)M Ribera, E Dauden, A Sahuquillo-Torralba, et al.
Actas Dermo-Sifiliograficas|June 15, 2017
Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular DiseaseC Bonanad, E González-Parra, R Rivera, et al.
Actas Dermo-Sifiliograficas|May 30, 2025
[Translated article] Expert Recommendations on Topical Therapy for Psoriasis from the Spanish Psoriasis Working Group (GPS)M Ribera, E Dauden, A Sahuquillo-Torralba, et al.
Journal of Investigational Allergology & Clinical Immunology|June 15, 2023
Updated Review on Treatment of Atopic DermatitisJ C Armario-Hita, M Galán-Gutiérrez, J M Dodero-Anillo, et al.
Actas Dermo-Sifiliograficas|May 27, 2023
Moderate to Severe Psoriasis in Older Adults: Recommendations on Management from the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology (AEDV)J Mataix, L García, I Belinchón, et al.
Actas Dermo-Sifiliograficas|July 28, 2023
[Translated article] Moderate to Severe Psoriasis in Older Adults: Recommendations on Management From the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology (AEDV)J Mataix, L García, I Belinchón, et al.
Actas Dermo-Sifiliograficas|August 5, 2024
[Translated article] Study of the Impact of Restrictions on Access to Biological Drugs for the Management of Psoriasis on the Minimum Disease Activity Criteria: Subanalysis of AEDV EQUIDAD and AME ProjectsM Sánchez-Díaz, Á Flórez, G Carretero-Hernández, et al.
Photodermatology, Photoimmunology & Photomedicine|January 7, 2015
Toll-like receptor 9 promoter polymorphism as a predictive factor of narrow-band UVB phototherapy response in patients with psoriasisJorge Romaní, Marc Julià, Francisco Lozano, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2020
Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trialR B Warren, J M Carrascosa, E Fumero, et al.
Pageof 25

Showing results (111-120 of 242) with videos related to

Sort By:
Pageof 25
Clinical and Experimental Dermatology|October 23, 2012
Lipopolysaccharide-binding protein is increased in patients with psoriasis with metabolic syndrome, and correlates with C-reactive proteinJ Romaní, A Caixàs, X Escoté, et al.
Actas Dermo-Sifiliograficas|March 9, 2025
Expert Recommendations on Topical Therapy for Psoriasis from the Spanish Psoriasis Working Group (GPS)M Ribera, E Dauden, A Sahuquillo-Torralba, et al.
Actas Dermo-Sifiliograficas|June 15, 2017
Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular DiseaseC Bonanad, E González-Parra, R Rivera, et al.
Actas Dermo-Sifiliograficas|May 30, 2025
[Translated article] Expert Recommendations on Topical Therapy for Psoriasis from the Spanish Psoriasis Working Group (GPS)M Ribera, E Dauden, A Sahuquillo-Torralba, et al.
Journal of Investigational Allergology & Clinical Immunology|June 15, 2023
Updated Review on Treatment of Atopic DermatitisJ C Armario-Hita, M Galán-Gutiérrez, J M Dodero-Anillo, et al.
Actas Dermo-Sifiliograficas|May 27, 2023
Moderate to Severe Psoriasis in Older Adults: Recommendations on Management from the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology (AEDV)J Mataix, L García, I Belinchón, et al.
Actas Dermo-Sifiliograficas|July 28, 2023
[Translated article] Moderate to Severe Psoriasis in Older Adults: Recommendations on Management From the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology (AEDV)J Mataix, L García, I Belinchón, et al.
Actas Dermo-Sifiliograficas|August 5, 2024
[Translated article] Study of the Impact of Restrictions on Access to Biological Drugs for the Management of Psoriasis on the Minimum Disease Activity Criteria: Subanalysis of AEDV EQUIDAD and AME ProjectsM Sánchez-Díaz, Á Flórez, G Carretero-Hernández, et al.
Photodermatology, Photoimmunology & Photomedicine|January 7, 2015
Toll-like receptor 9 promoter polymorphism as a predictive factor of narrow-band UVB phototherapy response in patients with psoriasisJorge Romaní, Marc Julià, Francisco Lozano, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2020
Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trialR B Warren, J M Carrascosa, E Fumero, et al.
Pageof 25